# Metagenomi Therapeutics, Inc.: Form 8-K, filed Oct 1, 2025

- Company: [Metagenomi Therapeutics, Inc.](/companies/mgx.md) (CIK 1785279)
- Form: 8-K
- Filed: 2025-10-01
- Accepted by EDGAR: Oct 1, 2025, 16:47 ET
- Period: 2025-09-29
- Accession: 0001193125-25-226878
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1785279/000119312525226878/mgx-20250929.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785279/000119312525226878/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785279/000119312525226878/mgx-20250929.htm

Filed Oct 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-226878. Last ingested by Listed: Nov 11, 2026, 00:33 ET. No prices; not investment advice.
